Characteristics of ST-Elevation Myocardial Infarction during the SARS-CoV-2 Outbreak

Machado, Guilherme Pinheiro; Araujo, Gustavo Neves de; Beltrame, Rafael; Theobald, André Luiz; Niches, Matheus de Souza; Fracasso, Julia Fagundes; Milan, Victoria; Custodio, Julia Luchese; Cardoso, Camila Porto; Tietz, Pedro Henrique Torres; Reichert, Giulia Bonatto; Schmidt, Marcia Moura; Quadros, Alexandre Schaan de; Wainstein, Marco Vugman.
Int. j. cardiovasc. sci. (Impr.) ; 37: e20220203, 2024. tab, graf
Artículo en Inglés | LILACS-Express | ID: biblio-1534610

Documentos relacionados

  1. Effect of Covid-19 pandemic process on STEMI patients timeline.
  2. Generation of infectious waste during the COVID-19 pandemic: The case of a Brazilian hospital.
  3. Design aspects of COVID-19 treatment trials: Improving probability and time of favorable events.
  4. Impact of the SARS-CoV-2 on the journey of high-risk colon cancer patients within the scope of the Unified Health System in Brazil.
  5. Real-world clinical outcomes of treatment with casirivimab-imdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemic.
  6. Impact of the COVID-19 Pandemic on ST-elevation Myocardial Infarction from a Single-center Experience in Tokyo.
  7. Effect of montelukast therapy on clinical course, pulmonary function, and mortality in patients with COVID-19.
  8. Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial infarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial infarction registry).
  9. The effect of ivermectin on non-severe and severe COVID-19 disease and gender-based difference of its effectiveness.
  10. Emergency General Surgery and COVID-19 Pandemic: Are There Any Changes? A Scoping Review.